Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Serotonin receptors: their key role in drugs to treat schizophrenia
HY Meltzer, Z Li, Y Kaneda, J Ichikawa - Progress in Neuro …, 2003 - Elsevier
Serotonin (5-HT)-receptor-based mechanisms have been postulated to play a critical role in
the action of the new generation of antipsychotic drugs (APDs) that are usually referred to as …
the action of the new generation of antipsychotic drugs (APDs) that are usually referred to as …
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment
The glutamate system is involved in many aspects of neuronal synaptic strength and
function during development and throughout life. Synapse formation in early brain …
function during development and throughout life. Synapse formation in early brain …
Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
Abstract Second-generation antipsychotics (SGAs), such as risperidone, clozapine and
olanzapine, are the most common drug treatments for schizophrenia. SGAs presented an …
olanzapine, are the most common drug treatments for schizophrenia. SGAs presented an …
The burden of antipsychotic-induced weight gain and metabolic syndrome in children
MR Libowitz, EL Nurmi - Frontiers in Psychiatry, 2021 - frontiersin.org
Antipsychotic medications are critical to child and adolescent psychiatry, from the
stabilization of psychotic disorders like schizophrenia, bipolar disorder, and psychotic …
stabilization of psychotic disorders like schizophrenia, bipolar disorder, and psychotic …
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research
MJ Arranz, J De Leon - Molecular psychiatry, 2007 - nature.com
The last decade of research into the pharmacogenetics of antipsychotics has seen the
development of genetic tests to determine the patients' metabolic status and the first attempts …
development of genetic tests to determine the patients' metabolic status and the first attempts …
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging
OD Howes, A Egerton, V Allan… - Current …, 2009 - ingentaconnect.com
Molecular imaging studies have generated important in vivo insights into the etiology of
schizophrenia and treatment response. This article first reviews the PET and SPECT …
schizophrenia and treatment response. This article first reviews the PET and SPECT …
Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide
C Van Heeringen, K Audenaert, K Van Laere… - Journal of affective …, 2003 - Elsevier
Background: Depression, hopelessness, impaired problem solving capacities and deficient
serotonergic functions have been identified as major causes of suicidal behaviour. In …
serotonergic functions have been identified as major causes of suicidal behaviour. In …
5‐HT radioligands for human brain imaging with PET and SPECT
The serotonergic system plays a key modulatory role in the brain and is the target for many
drug treatments for brain disorders either through reuptake blockade or via interactions at …
drug treatments for brain disorders either through reuptake blockade or via interactions at …
Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin–dopamine hypothesis
T Kuroki, N Nagao, T Nakahara - Progress in brain research, 2008 - Elsevier
Newer atypical antipsychotic drugs such as risperidone, olanzapine, quetiapine, ziprasidone
and aripiprazole that have been modelled on the prototype agent clozapine and developed …
and aripiprazole that have been modelled on the prototype agent clozapine and developed …
Hallucinations in schizophrenia, sensory impairment, and brain disease: a unifying model
RP Behrendt, C Young - Behavioral and Brain sciences, 2004 - cambridge.org
Based on recent insight into the thalamocortical system and its role in perception and
conscious experience, a unified pathophysiological framework for hallucinations in …
conscious experience, a unified pathophysiological framework for hallucinations in …